Investors Bag KPTI 26.8% Cheaper Than Its Secondary Stock Offering
June 04, 2020 at 16:27 PM EDT
Looking back to 93 days ago, Karyopharm Therapeutics Inc (KPTI) priced a 6,250,000 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..